Characterization of european ancestry nonalcoholic fatty liver disease‐associated variants in individuals of african and hispanic descent
dc.contributor.author | Palmer, Nicholette D. | en_US |
dc.contributor.author | Musani, Solomon K. | en_US |
dc.contributor.author | Yerges‐armstrong, Laura M. | en_US |
dc.contributor.author | Feitosa, Mary F. | en_US |
dc.contributor.author | Bielak, Lawrence F. | en_US |
dc.contributor.author | Hernaez, Ruben | en_US |
dc.contributor.author | Kahali, Bratati | en_US |
dc.contributor.author | Carr, J. Jeffrey | en_US |
dc.contributor.author | Harris, Tamara B. | en_US |
dc.contributor.author | Jhun, Min A. | en_US |
dc.contributor.author | Kardia, Sharon L.R. | en_US |
dc.contributor.author | Langefeld, Carl D. | en_US |
dc.contributor.author | Mosley, Thomas H. | en_US |
dc.contributor.author | Norris, Jill M. | en_US |
dc.contributor.author | Smith, Albert V. | en_US |
dc.contributor.author | Taylor, Herman A. | en_US |
dc.contributor.author | Wagenknecht, Lynne E. | en_US |
dc.contributor.author | Liu, Jiankang | en_US |
dc.contributor.author | Borecki, Ingrid B. | en_US |
dc.contributor.author | Peyser, Patricia A. | en_US |
dc.contributor.author | Speliotes, Elizabeth K. | en_US |
dc.date.accessioned | 2013-09-04T17:18:16Z | |
dc.date.available | 2014-10-06T19:17:41Z | en_US |
dc.date.issued | 2013-09 | en_US |
dc.identifier.citation | Palmer, Nicholette D.; Musani, Solomon K.; Yerges‐armstrong, Laura M. ; Feitosa, Mary F.; Bielak, Lawrence F.; Hernaez, Ruben; Kahali, Bratati; Carr, J. Jeffrey; Harris, Tamara B.; Jhun, Min A.; Kardia, Sharon L.R.; Langefeld, Carl D.; Mosley, Thomas H.; Norris, Jill M.; Smith, Albert V.; Taylor, Herman A.; Wagenknecht, Lynne E.; Liu, Jiankang; Borecki, Ingrid B.; Peyser, Patricia A.; Speliotes, Elizabeth K. (2013). "Characterization of european ancestry nonalcoholic fatty liver diseaseâ associated variants in individuals of african and hispanic descent." Hepatology 58(3): 966-975. <http://hdl.handle.net/2027.42/99594> | en_US |
dc.identifier.issn | 0270-9139 | en_US |
dc.identifier.issn | 1527-3350 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/99594 | |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.title | Characterization of european ancestry nonalcoholic fatty liver disease‐associated variants in individuals of african and hispanic descent | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.identifier.pmid | 23564467 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/99594/1/hep26440.pdf | |
dc.identifier.doi | 10.1002/hep.26440 | en_US |
dc.identifier.source | Hepatology | en_US |
dc.identifier.citedreference | FBPP Investigators. Multi‐center genetic study of hypertension: the Family Blood Pressure Program (FBPP). Hypertension 2002; 39: 3 ‐ 9. | en_US |
dc.identifier.citedreference | Bellentani S, Marino M. Epidemiology and natural history of non‐alcoholic fatty liver disease (NAFLD). Ann Hepatol 2009; 8 ( Suppl 1 ): S4 ‐ S8. | en_US |
dc.identifier.citedreference | Harrison SA, Neuschwander‐Tetri BA. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Clin Liver Dis 2004; 8: 861 ‐ 879, ix. | en_US |
dc.identifier.citedreference | Speliotes EK, Massaro JM, Hoffmann U, Vasan RS, Meigs JB, Sahani DV, et al. Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology 2010; 51: 1979 ‐ 1987. | en_US |
dc.identifier.citedreference | Stepanova M, Younossi ZM. Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population. Clin Gastroenterol Hepatol 2012; 10: 646 ‐ 650. | en_US |
dc.identifier.citedreference | Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, et al. The natural history of nonalcoholic fatty liver disease: a population‐based cohort study. Gastroenterology 2005; 129: 113 ‐ 121. | en_US |
dc.identifier.citedreference | Speliotes EK, Yerges‐Armstrong LM, Wu J, Hernaez R, Kim LJ, Palmer CD, et al. Genome‐wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet 2011; 7: e1001324. | en_US |
dc.identifier.citedreference | Limanond P, Raman SS, Lassman C, Sayre J, Ghobrial RM, Busuttil RW, et al. Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology 2004; 230: 276 ‐ 280. | en_US |
dc.identifier.citedreference | Kodama Y, Ng CS, Wu TT, Ayers GD, Curley SA, Abdalla EK, et al. Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol 2007; 188: 1307 ‐ 1312. | en_US |
dc.identifier.citedreference | Bohte AE, van Werven JR, Bipat S, Stoker J. The diagnostic accuracy of US, CT, MRI and 1H‐MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta‐analysis. Eur Radiol 2011; 21: 87 ‐ 97. | en_US |
dc.identifier.citedreference | Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Guallar E, et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta‐analysis. Hepatology 2011; 54: 1082 ‐ 1090. | en_US |
dc.identifier.citedreference | Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004; 40: 1387 ‐ 1395. | en_US |
dc.identifier.citedreference | Fan JG, Zhu J, Li XJ, Chen L, Li L, Dai F, et al. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J Hepatol 2005; 43: 508 ‐ 514. | en_US |
dc.identifier.citedreference | Mohanty SR, Troy TN, Huo D, O'Brien BL, Jensen DM, Hart J. Influence of ethnicity on histological differences in non‐alcoholic fatty liver disease. J Hepatol 2009; 50: 797 ‐ 804. | en_US |
dc.identifier.citedreference | Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 2010; 42: 105 ‐ 116. | en_US |
dc.identifier.citedreference | Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008; 40: 1461 ‐ 1465. | en_US |
dc.identifier.citedreference | Fuqua SR, Wyatt SB, Andrew ME, Sarpong DF, Henderson FR, Cunningham MF, et al. Recruiting African American research participation in the Jackson Heart Study: methods, response rates, and sample description. Ethn Dis 2005; 15: S6 ‐ 18‐29. | en_US |
dc.identifier.citedreference | Henkin L, Bergman RN, Bowden DW, Ellsworth DL, Haffner SM, Langefeld CD, et al. Genetic epidemiology of insulin resistance and visceral adiposity. The IRAS Family Study design and methods. Ann Epidemiol 2003; 13: 211 ‐ 217. | en_US |
dc.identifier.citedreference | Hamaguchi M, Kojima T, Itoh Y, Harano Y, Fujii K, Nakajima T, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol 2007; 102: 2708 ‐ 2715. | en_US |
dc.identifier.citedreference | Higgins M, Province M, Heiss G, Eckfeldt J, Ellison RC, Folsom AR, et al. NHLBI Family Heart Study: objectives and design. Am J Epidemiol 1996; 143: 1219 ‐ 1228. | en_US |
dc.identifier.citedreference | Almasy L, Blangero J. Multipoint quantitative‐trait linkage analysis in general pedigrees. Am J Hum Genet 1998; 62: 1198 ‐ 1211. | en_US |
dc.identifier.citedreference | Schwimmer JB, Celedon MA, Lavine JE, Salem R, Campbell N, Schork NJ, et al. Heritability of nonalcoholic fatty liver disease. Gastroenterology 2009; 136: 1585 ‐ 1592. | en_US |
dc.identifier.citedreference | Wagenknecht LE, Scherzinger AL, Stamm ER, Hanley AJ, Norris JM, Chen YD, et al. Correlates and heritability of nonalcoholic fatty liver disease in a minority cohort. Obesity (Silver Spring) 2009; 17: 1240 ‐ 1246. | en_US |
dc.identifier.citedreference | He S, McPhaul C, Li JZ, Garuti R, Kinch L, Grishin NV, et al. A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis. J Biol Chem 2010; 285: 6706 ‐ 6715. | en_US |
dc.identifier.citedreference | Beer NL, Tribble ND, McCulloch LJ, Roos C, Johnson PR, Orho‐Melander M, et al. The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver. Hum Mol Genet 2009; 18: 4081 ‐ 4088. | en_US |
dc.identifier.citedreference | Huang Y, Cohen JC, Hobbs HH. Expression and characterization of a PNPLA3 protein isoform (I148M) associated with nonalcoholic fatty liver disease. J Biol Chem 2011; 286: 37085 ‐ 37093. | en_US |
dc.identifier.citedreference | Basantani MK, Sitnick MT, Cai L, Brenner DS, Gardner NP, Li JZ, et al. Pnpla3/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome. J Lipid Res 2011; 52: 318 ‐ 329. | en_US |
dc.identifier.citedreference | Rees MG, Wincovitch S, Schultz J, Waterstradt R, Beer NL, Baltrusch S, et al. Cellular characterisation of the GCKR P446L variant associated with type 2 diabetes risk. Diabetologia 2012; 55: 114 ‐ 122. | en_US |
dc.identifier.citedreference | Graff M, North KE, Franceschini N, Reiner AP, Feitosa M, Carr JJ, et al. PNPLA3 gene‐by‐visceral adipose tissue volume interaction and the pathogenesis of fatty liver disease: The NHLBI Family Heart Study. Int J Obes (Lond) 2013; 37: 432 ‐ 438. | en_US |
dc.identifier.citedreference | Wagenknecht LE, Palmer ND, Bowden DW, Rotter JI, Norris JM, Ziegler J, et al. Association of PNPLA3 with non‐alcoholic fatty liver disease in a minority cohort: the Insulin Resistance Atherosclerosis Family Study. Liver Int 2011; 31: 412 ‐ 416. | en_US |
dc.identifier.citedreference | Santoro N, Savoye M, Kim G, Marotto K, Shaw MM, Pierpont B, et al. Hepatic fat accumulation is modulated by the interaction between the rs738409 variant in the PNPLA3 gene and the dietary omega6/omega3 PUFA intake. PLoS One 2012; 7: e37827. | en_US |
dc.identifier.citedreference | Kathiresan S, Melander O, Anevski D, Guiducci C, Burtt NP, Roos C, et al. Polymorphisms associated with cholesterol and risk of cardiovascular events. N Engl J Med 2008; 358: 1240 ‐ 1249. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.